Arrowhead Pharmaceuticals (NASDAQ: ARWR) has signed an agreement with an undisclosed third party to acquire a U.S. Food and Drug ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Mergers and Acquisitions